Igor Aurer

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Chronic Lymphocytic Leukemia

Mesenchymal Stem Cells

Top Venues

Healthcare (Basel, Switzerland)

Leukemia & lymphoma

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Igor Aurer, Ozren Jaksic, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Robert Likic, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines 12 (2) (2024)
Igor Aurer, Ozren Jaksic, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Robert Likic, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines 12 (2) (2024)
Denis Horgan, Jan Walewski, Igor Aurer, Chiara Rusconi, Eva Giné, Bogdan Fetica, Mats Jerkeman, Marta Kozaric, Maria Gomes da Silva, Martin Dreyling
Tackling Mantle Cell Lymphoma in Europe. Healthcare (Basel, Switzerland) 10 (9) (2022)
Sandra Bašić Kinda, Ivo Radman, Dino Dujmović, Ivana Ilić, Marko Kralik, Margareta Dobrenić, Lea Galunic Bilic, Pavle Rončević, Marijo Vodanović, Zrinka Sertić, Ida Hude Dragičević, Igor Aurer
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience. Annals of hematology 100 (6) (2020)
Martin Dreyling, Igor Aurer, Sergio Cortelazzo, Olivier Hermine, Georg Hess, Mats Jerkeman, Steven Le Gouill, Vincent Ribrag, Marek Trněný, Carlo Visco, Jan Walewski, Francesco Zaja, Pier Luigi Luigi Zinzani
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations. Leukemia & lymphoma 59 (8) (2017)